Semasize 0.25mg 0.5 Injection Semaglutide (1 Multi-dose Disposable Pen, 6 Needle, 6 Alcohol Swab)
Semasize 0.25mg/0.5 Injection is a semaglutide injection used to manage type 2 diabetes and support weight loss. It helps control blood sugar, suppress appetite, and improves metabolic health when combined with diet and physical activity.
Product Overview
Semasize (Semaglutide) Injection is designed for the management of type 2 diabetes and chronic weight management. It contains Semaglutide, is an advanced glucagon-like peptide-1 (GLP-1) receptor agonist. This medication works by mimicking the natural hormones that regulate blood sugar levels and appetite. By enhancing insulin secretion in response to glucose and slowing gastric emptying, Semasize helps patients achieve better glycemic control and sustained weight loss. The multi-dose disposable pen is engineered for precision and ease of use, allowing for convenient subcutaneous administration once a week.
Product Composition
- Active Ingredient: Semaglutide
- Concentration: Available in strengths corresponding to 0.25 mg or 0.5 mg per dose.
- Excipients: Disodium phosphate dihydrate, propylene glycol, phenol, and water for injection.
- Packaging: 1 Multi-dose Disposable Pen, 6 Disposable Needles, and 6 Alcohol Swabs.
- Action Category: GLP-1 Receptor Agonist / Antidiabetic / Anti-obesity.
Product Specifications
| Feature | Description |
| Therapeutic Class | Incretin Mimetic |
| Route of Administration | Subcutaneous Injection |
| Dosing Frequency | Once Weekly |
| Delivery System | Pre-filled, Multi-dose Dial-a-dose Pen |
Mechanism of Action
- Glucose-Dependent Insulin Secretion: Stimulates the pancreas to release insulin only when blood sugar levels are high, reducing the risk of hypoglycemia.
- Glucagon Suppression: Lowers inappropriately high glucagon secretion, which prevents the liver from releasing excess sugar into the bloodstream.
- Gastric Emptying Delay: Slows the rate at which food leaves the stomach, leading to a more gradual absorption of nutrients and lower post-meal glucose spikes.
- Appetite Regulation: Acts on specific receptors in the brain to increase feelings of fullness (satiety) and decrease hunger signals, supporting long-term caloric reduction.
Key Benefits
- Significant Glycemic Control: Effectively lowers HbA1c levels, helping patients reach their target blood sugar ranges.
- Weight Management Support: Promotes clinically meaningful weight loss by reducing appetite and slowing digestion.
- Cardiovascular Protection: Clinical evidence suggests a reduction in the risk of major adverse cardiovascular events in patients with established heart disease.
- Convenient Weekly Dosing: The once-weekly schedule improves patient adherence compared to daily medications.
- Complete Kit: Includes all necessary accessories (needles and swabs) for a sterile and ready-to-use experience.
Precautions
General Precautions
| Aspect | Precaution |
|---|---|
| Medical Supervision | Use only under strict doctor guidance for proper dosing and monitoring |
| Thyroid Disorders | Avoid use in patients with history of thyroid tumors or related conditions |
| Pancreatitis Risk | Use cautiously in patients with history of pancreatitis |
| Kidney Function | Monitor kidney health, especially in patients with existing kidney issues |
| Pregnancy & Breastfeeding | Use only if clearly prescribed by a healthcare professional |
Key Safety Guidelines
- Follow prescribed dosage schedule and do not self-adjust dose
- Inject as instructed using proper technique and hygiene
- Rotate injection sites to avoid skin irritation
- Monitor blood sugar levels regularly during treatment
- Inform your doctor about all medications and medical conditions
- Avoid skipping doses or doubling doses without advice
- Store the injection as per recommended conditions
Important Note
- Discontinue use and seek medical help if severe abdominal pain or signs of pancreatitis occur
- Report symptoms like neck swelling or difficulty swallowing immediately
- Regular monitoring is essential for safe and effective diabetes management
Usage
Usage Guidelines
| Step | Instruction |
| Preparation | Check the solution in the pen; it should be clear and colorless. Clean the injection site with an alcohol swab. |
| Attachment | Take a new disposable needle and screw it straight and tightly onto the pen. |
| Priming | For the first use of a new pen, check the flow by dialing to the flow check symbol and pressing the button. |
| Selection | Turn the dose selector until the prescribed dose (0.25 mg or 0.5 mg) aligns with the dose pointer. |
| Injection | Insert the needle into the skin of the abdomen, thigh, or upper arm; press and hold the button until the counter returns to 0. |
| Completion | Keep the needle in the skin for at least 6 seconds after the counter hits 0, then remove and safely discard the needle. |
Dosage & Administration
Semasize must be administered according to a strict schedule to ensure tolerance and efficacy:
Administer the injection once weekly, on the same day each week, at any time of day.
The dose can be taken with or without meals.
Initiate treatment with a starting dose of 0.25 mg once weekly for the first 4 weeks to allow the body to adjust.
After 4 weeks, the dose is typically increased to 0.5 mg once weekly.
Rotate the injection site with each dose to reduce the risk of skin irritation or lumps; do not use the exact same spot every time.
If a dose is missed, it should be administered within 5 days of the missed dose; if more than 5 days have passed, skip the missed dose and resume on the next regularly scheduled day.
Store the pen in the refrigerator ($2^{\circ}C$ to $8^{\circ}C$) before first use; after the first use, the pen can be kept at room temperature or in the refrigerator for up to 56 days.
Uses
Type 2 Diabetes Management: Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Chronic Weight Management: Used for long-term weight reduction in individuals with a high Body Mass Index (BMI) or weight-related medical conditions.
Cardiovascular Risk Reduction: Helps lower the risk of major cardiovascular events such as heart attack or stroke in patients with type 2 diabetes and established heart disease.
HbA1c Reduction: Effectively lowers long-term blood sugar markers to help prevent diabetic complications.
Side effects
Common Side Effects
- Nausea or vomiting
- Diarrhea or constipation
- Decreased appetite
- Abdominal discomfort or bloating
Less Common Side Effects
- Indigestion or acid reflux
- Fatigue or weakness
- Dizziness
- Mild injection site reactions such as redness or itching
Rare Side Effects
| Rare Side Effect | Description |
|---|---|
| Pancreatitis | Severe abdominal pain that may radiate to the back requiring immediate medical attention |
| Thyroid Tumors | Rare risk of thyroid gland abnormalities including swelling or lumps |
| Severe Hypoglycemia | Very low blood sugar especially when used with other antidiabetic drugs |
| Kidney Function Changes | Worsening kidney function in susceptible individuals |
| Severe Allergic Reaction | Rash, swelling, or difficulty breathing requiring urgent care |
Safety Note
- Seek immediate medical attention if symptoms of pancreatitis or severe allergic reaction occur
- Monitor blood sugar levels regularly during treatment
- Consult your doctor if side effects persist or worsen
- Use only under medical supervision for safe and effective results
FAQs
Q: What is Semasize Injection used for?
A: Semasize Injection is used for the management of type 2 diabetes mellitus and for chronic weight management in adults with obesity or overweight conditions. It contains Semaglutide, a GLP-1 receptor agonist that helps lower blood sugar levels, reduces appetite, and supports significant and sustained weight loss when used alongside a healthy diet and regular exercise.
Q: How does Semasize Injection work?
A: Semasize Injection works by activating GLP-1 receptors in the pancreas, brain, and digestive system. In the pancreas, it stimulates insulin secretion and suppresses glucagon release to lower blood sugar levels. In the brain, it reduces appetite and food cravings. It also slows gastric emptying, which helps control blood sugar spikes after meals and promotes a feeling of fullness for longer.
Q: How is Semasize Injection administered?
A: Semasize Injection is administered as a subcutaneous injection, meaning it is injected under the skin. It is typically injected once weekly in the abdomen, thigh, or upper arm. Always follow your doctor's instructions for the correct injection technique, dose, and injection site rotation to ensure safe and effective administration.
Q: What is the starting dose of Semasize Injection?
A: The starting dose of Semasize Injection is typically 0.25mg once weekly for the first 4 weeks. This initial low dose is intended to help the body adjust to the medication and minimise gastrointestinal side effects. Your doctor will gradually increase the dose to 0.5mg or higher based on your individual response and treatment goals.
Q: How long does it take for Semasize Injection to show results?
A: Most patients begin to notice improvements in blood sugar control within the first few weeks of starting treatment. Visible weight loss results typically become apparent within 8 to 12 weeks of consistent use. Optimal results for both diabetes management and weight loss are generally achieved over several months of continued treatment.
Q: Can Semasize Injection be used for weight loss alone?
A: Semasize Injection can be prescribed for chronic weight management in adults with obesity or overweight conditions with at least one weight-related health condition. It should always be used as part of a comprehensive weight management programme that includes a reduced-calorie diet and increased physical activity under medical supervision.
Q: Can Semasize Injection be used for type 1 diabetes?
A: No, Semasize Injection is not indicated for the treatment of type 1 diabetes mellitus. It is specifically approved for use in adults with type 2 diabetes mellitus. Individuals with type 1 diabetes should consult their doctor for appropriate insulin-based treatment options.
Q: What are the common side effects of Semasize Injection?
A: Common side effects include nausea, vomiting, diarrhoea, constipation, stomach pain, and decreased appetite. These gastrointestinal side effects are most common during the initial dose escalation period and typically improve as the body adjusts to the medication. Consult your doctor if side effects are persistent or severe.
Q: Can Semasize Injection cause low blood sugar?
A: Semasize Injection alone has a low risk of causing hypoglycaemia, also known as low blood sugar. However, the risk increases when it is used in combination with other diabetes medications such as insulin or sulfonylureas. Monitor your blood sugar levels regularly and inform your doctor if you experience symptoms of hypoglycaemia such as dizziness, sweating, or confusion.
Q: Can Semasize Injection affect the pancreas?
A: Semaglutide has been associated with a rare risk of pancreatitis, which is inflammation of the pancreas. Seek immediate medical attention if you experience severe and persistent abdominal pain that may radiate to the back during treatment with Semasize Injection.
Q: Can Semasize Injection be used during pregnancy and breastfeeding?
A: Semasize Injection is not recommended during pregnancy or breastfeeding. Semaglutide may cause harm to the developing foetus and its safety during lactation has not been established. Women planning pregnancy should discontinue Semasize Injection at least two months before conception and consult their doctor for safe alternative treatments.
Q: Can Semasize Injection affect the thyroid?
A: Semaglutide has been associated with a potential risk of thyroid C-cell tumours in animal studies. While the relevance to humans is not fully established, Semasize Injection is contraindicated in individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Inform your doctor of any thyroid-related history before starting treatment.
Q: Can I inject Semasize Injection in the same spot every week?
A: No, it is important to rotate injection sites with each weekly dose to prevent lipodystrophy, which refers to changes in fat tissue at the injection site. Alternate between the abdomen, thigh, and upper arm and choose a different spot within the same area each week for safe and comfortable administration.
Q: Can Semasize Injection interact with other medications?
A: Semasize Injection may interact with oral medications by slowing gastric emptying, which can affect the absorption rate of other drugs. Inform your doctor about all medications, supplements, and herbal products you are currently taking before starting Semasize Injection to avoid potential drug interactions.
Q: Where should I store Semasize Injection?
A: Store unused Semasize Injection pens in the refrigerator between 2 degrees Celsius and 8 degrees Celsius. Do not freeze. Once in use, the pen can be stored at room temperature below 30 degrees Celsius for up to 6 weeks. Keep out of direct sunlight, away from heat, and out of reach of children. Always check the expiry date before use.
| Manufacturer | : | Alkem Laboratories Ltd |
| Trade Name | : | Ozempic |
| Generic Search | : | Semaglutide |
| Strength | : | 0.25mg/0.5 mg |
Latest Products
